Sign Out
No interaction studies with other medicinal products have been performed.
In vitro studies have shown that Olopatadine did not inhibit metabolic reactions that involve cytochrome P-450 isozymes 1A2, 2C8, 2C9, 2C19, 2D6, 2E1, and 3A4. These results indicate that Olopatadine is unlikely to result in metabolic interactions with other concomitantly administered active substances.
